MAGNER, MARTIN

Professor Martin Magner, MD, PhD, MBA, is an Associate Professor in the Department of Paediatrics and Inherited Metabolic Disorders at Charles University, General University Hospital, Czech Republic. He specializes in pediatric metabolic diseases, mitochondrial disorders, and lysosomal storage disorders, contributing to advancements in clinical research and therapeutic interventions.

Prof. Magner earned his medical degree from the First Faculty of Medicine at Charles University in Prague, where he later pursued his PhD on the clinical manifestation of mitochondrial disorders in children. His research has provided critical insights into pediatric metabolic dysfunctions, shaping diagnostic and treatment strategies for rare metabolic diseases. Over time, his scientific focus expanded to lysosomal storage disorders, refining therapeutic approaches for inherited metabolic conditions.

He holds certifications in Paediatrics, Medical Genetics, Clinical Nutrition, and Intensive Metabolic Care, ensuring that children with complex metabolic disorders receive specialized, evidence-based treatment. His expertise spans nutritional interventions, metabolic disease management, and pediatric genetic disorders, integrating clinical practice with translational research.

Prof. Magner has served as a principal investigator in multiple clinical trials, evaluating novel therapies for metabolic diseases. He has authored or co-authored over 90 peer-reviewed scientific publications and more than 30 textbook chapters, contributing to global discussions on pediatric metabolic health. His work has helped refine guidelines for diagnosing and managing inherited metabolic disorders, ensuring that children with rare diseases receive optimal care.

Beyond his research, Prof. Magner is actively involved in medical education and mentorship, training healthcare professionals in pediatric metabolic medicine. His contributions to pediatric metabolic research, clinical nutrition, and rare disease management continue to shape the field, improving diagnostic accuracy and treatment strategies for children with inherited metabolic disorders.

‍